CHD at baseline and after 48 months, and evaluation of CV risk evolution (evaluated by UKPDS RE) by gender (t-test) at baseline, after 12 months, and after 48 months
| Males | Females | Effect | Mean difference | ||
|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | size | and 95% CI | p Value | |
| CHD at baseline | 21/106 (19.81%) | 4/64 (6.25%) | |||
| CHD after 48 months | 27/106 (25.47%) | 5/64 (7.81%) | |||
| UKPDS at baseline | 1.36 (0.24) | 1.14 (0.23) | 0.91 | 0.22 (0.14 to 0.29) | <0.0001 |
| UKPDS after 12 months | 1.30 (0.25) | 1.12 (0.25) | 0.73 | 0.19 (0.11 to 0.26) | <0.0001 |
| UKPDS after 48 months | 1.33 (0.25) | 1.12 (0.23) | 0.85 | 0.21 (0.13 to 0.28) | <0.0001 |
CHD, coronary heart disease; CV, cardiovascular; UKPDS RE, the UK Prospective Diabetes Study Risk Engine.